Try our Advanced Search for more refined results
November 09, 2009
Track this case
3:09-cv-05693
New Jersey
Personal Inj. Prod. Liability
Freda L. Wolfson
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
The U.S. Food and Drug Administration is revising the label on bisphosphonate-based osteoporosis drugs to warn consumers that they could raise the risk of a rare type of thigh-bone fracture.
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login